Certara, Inc. Common Stock CERT

$10.63 -0.47% at last close
Market Cap$1.63 billion
P/E Ratio—
Div Yield—
Volume204.7K
52-Week Range $4.45$12.94

Analyst Ratings

Consensus
Moderate Buy — 4 Buy · 6 Hold · 0 Sell (10 analysts)
Avg. Price Target
$9.70 (-8.7% downside)

Full CERT forecast & analyst actions →

Key Stats

Today's Range
$10.42 – $10.86
50-Day Range
$7.58 – $12.61
52-Week Range
$4.45 – $12.94
Volume
205K shs
Average Volume
2.47 million shs
Market Cap
$1.63 billion
P/E Ratio
—
Dividend Yield
—

Short Interest

Short Interest
0.72%
Days to Cover
1.00

About Certara, Inc. Common Stock

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Sector
SERVICES-PREPACKAGED SOFTWARE
Employees
1,576
Exchange
XNAS
Listed
2020-12-11

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.